R3 Stem Cell International

Light chain amyloidosis results from clonal plasma cells; however, cell therapy directed against these clone cells has remained the most effective treatment for the condition. Over time, autologous stem cell transplantation (ASCT) has become a critical treatment resource for addressing light-chain amyloidosis.Following ASCT, patients with...

Today, stem cell therapy is utilized in many applications, with some of the most predominant applications linked to musculoskeletal injuries and ailments. Yet, as the treatment continues to develop, experts find them effective in other new areas, such as cerebrovascular conditions.Recent tests have pitted stem...

Doctors utilize different treatment modalities for patients, each selected based on the most effective way to address the patient’s condition. However, stem cell treatment has been touted as the most effective in situations requiring rapid healing and recovery.Regardless, most people are still not sold on...

R3 Stem Cell and Founder Dr. David Greene have been featured in the Cover story for 10 Best Healthcare Companies to Watch in 2022 by Silicon Review Magazine. After a decade of providing first-rate regenerative therapies, R3 has become the global leader for patients desiring safe, effective...